Effects of insulin detemir on balloon catheter injured carotid artery in Zucker fatty rats

J Diabetes Complications. 2012 Nov-Dec;26(6):470-5. doi: 10.1016/j.jdiacomp.2012.05.019. Epub 2012 Jul 4.

Abstract

Objective: We compared the effect of the long acting basal insulin analog detemir with neutral protamine Hagedorn (NPH) insulin, and normal saline on recovery from vascular injury (balloon catheter mediated) in an animal model of insulin resistance.

Methods: Female Zucker fatty rats were administered NPH/detemir/saline for 7 days following which, they underwent balloon catheter mediated injury of left carotid artery, and were continued on the respective regimen for an additional 21 days when they were sacrificed. We evaluated the injured carotid artery for intimal hyperplasia (Intima/Media ratio) and also, aortic arch protein for markers of oxidative stress and inflammation, in addition to expression and phosphorylation of eNOS using well established methods.

Results: There was a significant difference in intimal hyperplasia (Intima/Media ratio) between control and detemir treated rats (1.3±0.09, 0.82±0.08; p<0.001) whereas the IM ratio in NPH treated rats was not significantly different from saline (1.17±0.1). Expression of p-eNOS (ser-1177) in both NPH and insulin detemir (1.3±0.15, 1.11±0.12) was significantly higher than controls (0.56±0.13; p<0.05). We did not find significant differences in the expression of MnSOD, eNOS and NFκB-p65.

Conclusion: We conclude that in insulin resistant states, treatment with Insulin detemir but not NPH is associated with less intimal hyperplasia, although both insulins increased eNOS phosphorylation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carotid Arteries / drug effects*
  • Carotid Arteries / immunology
  • Carotid Arteries / metabolism
  • Carotid Arteries / pathology
  • Carotid Artery Diseases / complications
  • Carotid Artery Diseases / immunology
  • Carotid Artery Diseases / pathology
  • Carotid Artery Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetic Angiopathies / immunology
  • Diabetic Angiopathies / metabolism
  • Diabetic Angiopathies / pathology
  • Diabetic Angiopathies / prevention & control*
  • Disease Models, Animal*
  • Female
  • Hyperplasia
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Detemir
  • Insulin Resistance*
  • Insulin, Isophane / therapeutic use
  • Insulin, Long-Acting / therapeutic use*
  • Nitric Oxide Synthase Type III / metabolism
  • Obesity / complications
  • Oxidative Stress / drug effects
  • Phosphorylation / drug effects
  • Protein Processing, Post-Translational / drug effects
  • Rats
  • Rats, Zucker
  • Tunica Intima / drug effects
  • Tunica Intima / immunology
  • Tunica Intima / metabolism
  • Tunica Intima / pathology

Substances

  • Hypoglycemic Agents
  • Insulin, Long-Acting
  • Insulin Detemir
  • Insulin, Isophane
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat